LONDON — Tate & Lyle PLC has reached an agreement to acquire Quantum Hi-Tech Biological Co., Ltd. from ChemPartner Pharmatech Co., Ltd. for $237 million. Founded in 2000 and headquartered in Guangdong, China, Quantum specializes in the research, development, production and sale of fructo-oligosaccharides (FOS) and galacto-oligosaccharides (GOS).
Tate & Lyle said the acquisition of Quantum “significantly strengthens” its position as a leading global player in dietary fibers, expanding its ability to provide added-fiber solutions across a range of categories, including dairy, beverages, baked foods and nutrition. The acquisition also expands Tate & Lyle’s presence in China and Asia and extends its capabilities to create solutions across food and drink categories using its specialty ingredients portfolio.
“We are delighted to announce the agreement to acquire Quantum, a leader in prebiotic dietary fibers and a business…
